Circular No. 20/2017/TT-BYT stipulates the maximum price of a whole blood unit and blood products that meet standards, as well as the costs for determining these prices. It specifies the specific prices for each type of blood and product, and provides guidance on calculating transportation and testing costs related to receiving, screening, producing, storing, and distributing blood. Additionally, it sets out other reasonable costs serving this work and requires healthcare facilities to post prices in accordance with the law.
Đối tượng áp dụng
Healthcare facilities and entities involved in receiving, screening, producing, storing, and distributing whole blood and blood products that meet standards.
Các điểm cốt lõi
- The maximum price for a whole blood unit and blood products
- Costs for transporting blood from the supplying unit to the using unit
- Mandatory testing costs according to regulations
- Other reasonable costs serving the work of receiving, screening, producing, storing, and distributing blood.
- Requirement to post prices in accordance with the law
🌐 Tác động xã hội từ văn bản này
- Ensuring the quality and safety of blood and blood products
- Ensuring fairness in fees for services related to blood and blood products
- Providing a legal basis for managing and adjusting prices in the healthcare sector
❓ Câu hỏi thường gặp
When does this circular take effect?
Circular No. 20/2017/TT-BYT takes effect from June 1, 2017.
Are previous documents related to blood and blood product prices replaced?
Circular No. 33/2014/TT-BYT of the Ministry of Health stipulating the maximum price and costs for determining the price of a whole blood unit and blood products that meet standards becomes invalid from the date this circular takes effect.
What must healthcare facilities do to comply with the circular?
Healthcare facilities must maintain records of the situation regarding the receipt and use of funds related to blood and blood products, declare prices, and post prices in accordance with the law.
Toàn văn
CIRCULAR
PROVISIONS ON THE MAXIMUM PRICE AND COSTS FOR SERVICING THE DETERMINATION OF THE PRICE OF A UNIT OF WHOLE BLOOD AND QUALIFIED BLOOD PRODUCTS
Pursuant to the Medicine Law No. 105/2016/QH13 dated April 6, 2016;
BASED ON THE Law on Prices number 11/2012/QH13 dated June 20, 2012;
PURSUANTBASED ON Decree number 63/2012/NĐ-CP dated August 31, 2012 of the Government stipulating the functions, tasks, powers, and organizational structure of the Ministry of Health;
ON THE BASIS OF THE opinions of the Ministry of Finance in Circular number 422/BTC-QLG dated January 11, 2017;
At the proposal of the Director of the Department of Planning and Finance;
The Minister of Health issues this Circular regulating the maximum price and service costs for determining the price of a unit of whole blood and standard blood products.
Article 1. Scope of Regulation and Applicability
2. Applicability:
THIS Circular stipulates the maximum price for certain units of whole blood and blood products meeting standards paid from the state budget and health insurance fund, and costs for valuing a unit of whole blood and blood products meeting standards.
第二条 组织和实施奖励工作的支出水平,如政府第152/2025/NĐ-CP号决定关于分级授权和奖励领域的分权规定
a) Blood donation volunteer steering committees at all levels; agencies, units, organizations participating in propaganda, mobilization, organization of voluntary blood donation, and blood donors;
b) Medical facilities with the function of selecting blood donors; receiving blood and blood components; screening blood tests; preparing blood products; storing, preserving, supplying, and using blood and blood products in accordance with the regulations of the Ministry of Health.
Article 2. Provisions on units of whole blood and blood products meeting standards.
1. A unit of whole blood meets the standard when it is collected, stored in plastic bags containing anticoagulants, and has undergone all mandatory screening tests as prescribed in Circular number 26/2013/TT-BYT dated September 16, 2013 of the Ministry of Health guiding blood transfusion activities (hereinafter referred to as Circular number 26/2013/TT-BYT).
2. A standard blood product meets the standards set out in Circular No. 26/2013/TT-BYT when it is prepared according to the prescribed standards.
Article 3. Provisions on the maximum prices of certain units of whole blood and standard blood products
1. Units of whole blood:
|
Serial number |
Whole blood by volume |
Actual volume |
Maximum price (VND) |
|
1 |
Whole blood 30 ml |
35 |
109.000 |
|
2 |
Whole blood 50 ml |
55 |
157.000 |
|
3 |
Whole blood 100 ml |
115 |
290.000 |
|
4 |
Whole blood 150 ml |
170 |
417.000 |
|
5 |
Whole blood 200 ml |
225 |
505.000 |
|
6 |
Whole blood 250 ml |
285 |
641.000 |
|
7 |
Whole blood 350 ml |
395 |
758.000 |
|
8 |
Whole blood 450 ml |
510 |
858.000 |
2. Red blood cell products:
|
Serial number |
Red blood cell products by volume |
Tourism actual volume |
Maximum price (VND) |
|
1 |
Red cell mass from 30 ml of whole blood |
20 |
114.000 |
|
2 |
Red cell mass from 50 ml of whole blood |
30 |
162.000 |
|
3 |
Red cell mass from 100 ml of whole blood |
70 |
280.000 |
|
4 |
Red cell mass from 150 ml of whole blood |
110 |
402.000 |
|
5 |
Red cell mass from 200 ml of whole blood |
145 |
520.000 |
|
6 |
Red cell mass from 250 ml of whole blood |
180 |
638.000 |
|
7 |
Red cell mass from 350 ml of whole blood |
230 |
748.000 |
|
8 |
Red cell mass from 450 ml of whole blood |
280 |
838.000 |
3. Blood In this Circular, the following terms are understood as follows: products:frozen fresh plasma:
|
Serial number |
Fresh frozen plasma products by volume |
Tourism actual volume |
Maximum price (VND) |
|
1 |
Fresh frozen plasma 30 ml |
30 |
64.000 |
|
2 |
Fresh frozen plasma 50 ml |
50 |
92.000 |
|
3 |
Fresh frozen plasma 100 ml |
100 |
155.000 |
|
4 |
Fresh frozen plasma 150 ml |
150 |
177.000 |
|
5 |
Fresh frozen plasma 200 ml |
200 |
280.000 |
|
6 |
Fresh frozen plasma 250 ml |
250 |
343.000 |
4. Frozen plasma products:
|
Serial number |
Frozen plasma products by volume |
Tourism actual volume |
Maximum price (VND) |
|
1 |
Frozen plasma 30 ml |
30 |
54.000 |
|
2 |
Frozen plasma 50 ml |
50 |
77.000 |
|
3 |
Frozen plasma 100 ml |
100 |
120.000 |
|
4 |
Frozen plasma 150 ml |
150 |
167.000 |
|
5 |
Frozen plasma 200 ml |
200 |
220.000 |
|
6 |
Frozen plasma 250 ml |
250 |
262.000 |
5. Platelet-rich plasma:6. Leukocyte-poor platelet concentrate:
|
Serial number |
Platelet-rich plasma products by volume |
Tourism actual volume |
Maximum price (VND) |
|
1 |
Platelet-rich plasma 100 ml from 250 ml of whole blood |
100 |
209.000 |
|
2 |
Platelet-rich plasma 150 ml from 350 ml of whole blood |
150 |
228.000 |
|
3 |
Platelet-rich plasma 200 ml from 450 ml of whole blood |
200 |
248.000 |
actual volume (ml) (±10%)9. Other
|
Serial number |
Platelet concentrate products by volume |
Tourism actual volume |
Maximum price (VND) |
|
1 |
Platelet concentrate 1 unit (from 250 ml of whole blood) |
40 |
140.000 |
|
2 |
Platelet concentrate 2 units (from 500 ml of whole blood) |
80 |
290.000 |
|
3 |
Platelet concentrate 3 units (from 750 ml of whole blood) |
120 |
445.000 |
|
4 |
Platelet concentrate 4 units (from 1,000 ml of whole blood) |
150 |
558.000 |
7. Cryoprecipitate products:
|
Serial number |
Cryoprecipitate products by volume |
Tourism using additional equipment and materials: |
Maximum price (VND) |
|
1 |
Cryoprecipitate volume 10 ml (from 250 ml of whole blood) |
10 |
78.000 |
|
2 |
Cryoprecipitate volume 50 ml (from 1,000 ml of whole blood) |
50 |
359.000 |
|
3 |
Cryoprecipitate volume 100 ml (from 2,000 ml of whole blood) |
100 |
638.000 |
8. Granulocyte products:
|
Serial number |
Granulocyte products by volume |
Tourism actual volume |
Maximum price (VND) |
|
1 |
Granulocyte pool (5x109 BC) |
125 |
339.000 |
|
2 |
Granulocyte pool (10x109 BC) |
250 |
678.000 |
10. The maximum prices specified in Clauses 1, 2, 3, 4, 5, 6, 7, 8, and 9 of this Article do not include the following costs: In this Circular, the following terms are understood as follows: a) Transportation costs from the facility providing blood to the user units. In cases where the blood-providing facilities transport blood to the user units, the price of each unit of blood and blood product may be increased by a maximum of VND 17,000 per unit of blood (blood product);
|
Serial number |
Products by volume |
Actual volume |
Maximum price (VND) |
|
1 |
Platelet concentrate 8 units (from 2,000 ml of whole blood) (excluding pooling bags and leukoreduction filters) |
250 |
1.068.000 |
|
2 |
Cryoprecipitate Factor VIII inactivated virus (excluding inactivation kit) |
50 |
713.000 |
|
3 |
Cost of preparing granulocyte concentrate (excluding centrifugation equipment) |
250 |
924.000 |
|
4 |
Cost of preparing platelet concentrate (excluding centrifugation equipment) |
250 |
924.000 |
|
5 |
Cost of preparing platelet concentrate (excluding centrifugation equipment) |
120 |
514.000 |
b) Costs for abnormal antibody testing according to the schedule prescribed in Point a Clause 1 and Point c Clause 4 of Article 14 of Circular number 26/2013/TT-BYT. In cases where blood transfusion facilities conduct abnormal antibody testing, the price of each unit of whole blood, red cell concentrates with a volume of 250 ml or more, and blood products including platelet concentrates, leukocyte-reduced platelet concentrates, and platelet concentrates may be increased by a maximum of VND 17,000 per unit;
c) Costs for NAT testing according to the schedule prescribed in Point b Clause 1 and Point g Clause 4 of Article 14 of Circular number 26/2013/TT-BYT. In cases where blood-providing facilities conduct NAT testing, the price of each unit of whole blood, red cell concentrates with a volume of 250 ml or more, and blood products including platelet concentrates, leukocyte-reduced platelet concentrates, and platelet concentrates may be increased by a maximum of VND 210,000 per unit;
d) Costs for mandatory conditional tests prescribed in Points a, b, c Clause 2 and Points c, i, k Clause 4 of Article 14 of Circular number 26/2013/TT-BYT. Blood-providing facilities only conduct these tests when they comply with current regulations on blood transfusion activities and have a doctor's prescription;
đ) Costs for blood group typing tests, immune compatibility tests, identification and determination of abnormal antibodies, bedside blood group typing, and equipment for administering blood and blood products to patients.
11. Medical facilities conducting tests at Points d, đ Clause 10 of this Article are permitted to charge patients or settle with the Health Insurance Fund according to the approved prices under current regulations.
The valuation of a unit of whole blood and blood products meeting standards is based on the costs for receiving, screening blood and blood components, and preparing blood products as follows:
Specific support expenses, levels of support expenses, and the use of this funding are implemented in accordance with Clause 2 of Article 3 of Circular number 182/2009/TT-BTC dated September 14, 2009 of the Ministry of Finance guiding the content and level of expenses for publicizing and mobilizing voluntary blood donation.
Article 4. Costs for determining the price of a whole blood unit and standard blood products
2. Food expenses at the place of donation for blood donors (including whole blood and blood components, both voluntary and professional donors): The average maximum expense is VND 30,000 per person per donation. Blood-providing facilities are responsible for organizing and publicly announcing food services before and after donation for donors.
1. Support costs for units and facilities engaged in publicizing, mobilizing, and organizing voluntary blood donation days: The maximum average cost is VND 50,000 per blood donor.
3. Direct compensation for professional blood donors:
a) For whole blood donors:
b) For donors who donate blood components through apheresis:
- One product with a volume from 250 to 400 ml: VND 400,000;
- One unit of blood with a volume of 250 ml: VND 195,000;
- One unit of blood with a volume of 350 ml: VND 320,000;
- One unit of blood with a volume of 450 ml: VND 430,000.
- One product with a volume from 400 to 500 ml: VND 600,000;
- One product with a volume from 500 to 650 ml: VND 700,000
4. Expenses for voluntary blood donors:
a) Gifts in kind aimed at encouraging and supporting the health of voluntary whole blood donors:
b) Gifts in kind aimed at encouraging and supporting the health of voluntary donors who donate blood components through apheresis (platelet concentrates, granulocyte concentrates, peripheral blood stem cells...):
- One product with a volume from 250 to 400 ml: VND 150,000;
- One unit of blood with a volume of 250 ml: VND 100,000;
- One unit of blood with a volume of 350 ml: VND 150,000;
- One unit of blood with a volume of 450 ml: VND 180,000.
- One product with a volume from 400 to 500 ml: VND 200,000;
- One product with a volume from 500 to 650 ml: VND 250,000;
6. Salary expenses according to rank, position, allowances, and contributions as prescribed by the State; Special allowance expenses as prescribed in Decision number 73/2011/QĐ-TTg dated December 28, 2011 of the Prime Minister regarding special allowances for civil servants, employees, and workers in public medical facilities and anti-epidemic allowances.
8. Clinical examination expenses, expenses for purchasing materials, chemicals, and reagents for mandatory tests as prescribed in Circular 26/2013/TT-BYT.
c) Support costs for travel expenses for voluntary blood donors: The maximum average cost is VND 50,000 per person per donation.
5. Costs for blood collection equipment, plastic blood bags, materials, office supplies, electricity, and water serving blood collection, testing, and screening, and blood product processing.
1. Heads of units shall base their specific pricing for each unit of whole blood and blood products meeting standards, transportation costs from blood-providing units to user units, and the tests specified in Points b, c Clause 10 of Article 3 of this Circular on the principles set forth in this Circular and the actual situation of their units.
7. Costs for renting vehicles, purchasing fuel when collecting blood at mobile blood collection points according to invoices and actual contracts.
8. Clinical examination costs, procurement costs for materials, chemicals, and biological reagents for laboratory tests as required by Circular 26/2013/TT-BYT.
9. Costs for regular maintenance and repair of assets and equipment serving the reception, screening, and storage of blood and blood products.
10. Costs for discarding blood units that do not meet standards.
11. Support costs for organizing counseling for voluntary blood donors at public health facilities assigned the task of receiving and screening blood.
12. Other reasonable and lawful costs serving the reception, screening, production, storage, and distribution of blood and blood products.
State-owned enterprises that have been assigned by the Ministry of Agriculture and Rural Development to conduct offshore wind power project surveys before the effective date of this Circular shall continue to implement according to the assigned documents; any new matters arising after the effective date of this Circular shall be implemented in accordance with the provisions of this Circular.
1. The head of the unit shall base on the provisions of this Circular and the actual situation of the unit to establish and issue specific prices for each whole blood unit and blood products that meet the standards, transportation costs from the blood supply unit to the using unit, and the tests specified in points b and c, Clause 10, Article 3 of this Circular, according to the following principles:
a) Not to exceed the maximum price specified in Article 3 of this Circular for cases of payment from state budget sources, revenue from medical examination and treatment services as prescribed by public health facilities, and the Health Insurance Fund.
b) To ensure compensation for actual reasonable costs, with accumulation, and be consistent with market conditions for cases of payment from sources not specified in Point a of this Clause.
2. In cases where blood supply facilities carry out blood transportation to using units and the tests prescribed in Points b and c of Clause 10 of Article 3 of this Circular, they may add the blood transportation cost and test cost to the price of each unit of blood and blood products for settlement with the Health Insurance Authority or collection from patients according to regulations, but must still comply with the principles stipulated in Clause 1 of this Article.
In special cases, where using units go to collect blood and blood products themselves to promptly serve blood transfusion work, they will be reimbursed by the Social Insurance Authority for blood and blood product transportation costs up to a maximum of VND 17,000 per unit of blood or blood product. The difference between the self-collection costs and the reimbursement amount (if any) will be covered by the operating funds of the using unit and settled accordingly.
Healthcare facilities must maintain records of the receipt, use of funds for reception, screening, preparation, storage, transportation, and use of blood and blood products, and implement price declaration and posting in accordance with legal provisions.
4. Budget preparation, execution, and settlement procedures shall be carried out in accordance with the current provisions of the State Budget Law, Accounting Law, and other guiding documents.
Article 6. Reference Provisions
In cases where the referenced documents in this document are replaced or amended, implementation shall be in accordance with the replacement or amended document.
Article 7. Implementation Provisions
1. This Circular takes effect from June 1, 2017.
2. Circular No. 33/2014/TT-BYT dated October 27, 2014 of the Ministry of Health on the maximum price and service costs for determining the price of a whole blood unit and blood products meeting standards becomes invalid from the date this Circular takes effect.
During implementation, any difficulties should be reported promptly to the Ministry of Health for appropriate amendments and supplements.
Văn bản gốc (PDF)
Bản đồ quan hệ
Bấm vào một văn bản để mở. Viền đỏ = quan hệ làm thay đổi hiệu lực.
Bản dịch
Văn bản này có sẵn ở các ngôn ngữ sau: